LANZA, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 14.781
AS - Asia 7.913
EU - Europa 6.312
SA - Sud America 1.261
Continente sconosciuto - Info sul continente non disponibili 338
AF - Africa 181
OC - Oceania 21
Totale 30.807
Nazione #
US - Stati Uniti d'America 14.350
SG - Singapore 2.954
IT - Italia 2.354
CN - Cina 1.883
BR - Brasile 988
DE - Germania 830
VN - Vietnam 817
HK - Hong Kong 649
UA - Ucraina 505
PL - Polonia 490
FR - Francia 425
GB - Regno Unito 422
TR - Turchia 405
FI - Finlandia 394
BD - Bangladesh 341
CA - Canada 210
SE - Svezia 206
IN - India 204
RU - Federazione Russa 202
JP - Giappone 186
NL - Olanda 144
MX - Messico 124
ID - Indonesia 118
AR - Argentina 95
ES - Italia 67
ZA - Sudafrica 67
AT - Austria 54
IQ - Iraq 54
BE - Belgio 45
PK - Pakistan 44
EC - Ecuador 42
PH - Filippine 36
VE - Venezuela 35
CO - Colombia 33
MA - Marocco 31
SA - Arabia Saudita 28
CH - Svizzera 27
JM - Giamaica 26
LT - Lituania 26
CL - Cile 22
UZ - Uzbekistan 22
AE - Emirati Arabi Uniti 20
AU - Australia 20
MY - Malesia 20
CZ - Repubblica Ceca 19
EG - Egitto 18
PY - Paraguay 17
TN - Tunisia 17
RO - Romania 16
BG - Bulgaria 15
JO - Giordania 14
CR - Costa Rica 13
UY - Uruguay 13
KR - Corea 12
KZ - Kazakistan 12
NI - Nicaragua 12
IE - Irlanda 11
AL - Albania 10
KE - Kenya 10
TH - Thailandia 10
AZ - Azerbaigian 9
DZ - Algeria 9
IL - Israele 9
IR - Iran 9
HN - Honduras 8
KG - Kirghizistan 8
PE - Perù 8
DK - Danimarca 7
DO - Repubblica Dominicana 7
GR - Grecia 7
NP - Nepal 7
OM - Oman 7
BO - Bolivia 6
GT - Guatemala 6
PT - Portogallo 6
RS - Serbia 6
SV - El Salvador 6
ET - Etiopia 5
HU - Ungheria 5
LB - Libano 5
SN - Senegal 5
TT - Trinidad e Tobago 5
PA - Panama 4
SY - Repubblica araba siriana 4
TW - Taiwan 4
BH - Bahrain 3
CI - Costa d'Avorio 3
GH - Ghana 3
HR - Croazia 3
KH - Cambogia 3
LU - Lussemburgo 3
MN - Mongolia 3
NO - Norvegia 3
PR - Porto Rico 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BB - Barbados 2
BY - Bielorussia 2
EU - Europa 2
LK - Sri Lanka 2
Totale 30.435
Città #
Singapore 1.825
Ashburn 1.659
San Jose 1.184
Woodbridge 1.012
Fairfield 1.003
Santa Clara 656
Hong Kong 634
Chandler 627
Beijing 591
Houston 564
Jacksonville 563
Ann Arbor 526
Warsaw 474
Council Bluffs 451
Seattle 387
Wilmington 341
New York 326
Cambridge 298
Ferrara 292
Los Angeles 257
Ho Chi Minh City 244
Izmir 229
Munich 222
Dallas 218
Milan 199
Nanjing 193
Hanoi 183
Helsinki 183
Tokyo 176
Dearborn 164
Rome 154
Princeton 153
Lauterbourg 126
Boardman 114
Bologna 107
San Diego 106
São Paulo 102
Shanghai 98
Orem 90
Turku 88
Chicago 85
Jakarta 83
Buffalo 72
Mexico City 72
Toronto 69
London 68
Nanchang 66
Hefei 64
Denver 58
Shenyang 58
The Dalles 58
Frankfurt am Main 56
Phoenix 55
Amsterdam 51
Nuremberg 49
Tianjin 48
Atlanta 47
Montreal 47
Naples 45
Palermo 44
Chennai 43
Da Nang 42
Brooklyn 41
Poplar 41
Stockholm 41
San Francisco 39
Brussels 37
Johannesburg 36
Boston 35
Manchester 34
Kunming 33
Redwood City 33
Changsha 32
Moscow 32
Bremen 31
Rio de Janeiro 31
Florence 29
Jinan 29
Ankara 28
Catania 28
Hebei 28
Jiaxing 27
Washington 27
Dong Ket 26
Guangzhou 26
Haiphong 26
Mumbai 26
Columbus 25
Falkenstein 25
Addison 23
Norwalk 23
Falls Church 22
San Mateo 22
Belo Horizonte 21
Brasília 21
Dhaka 20
Ningbo 20
Orange 20
Ottawa 20
Paris 20
Totale 19.177
Nome #
Adenoma-carcinoma del retto-colon. Linee guida e criteri diagnostici minimi. 1.367
Merkel cell carcinomas arising in autoimmune disease affected patients treated with biologic drugs including anti-TNF 460
Gene expression changes in progression of cervical neoplasia revealed by microarray analysis of cervical neoplastic keratinocytes 371
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. 368
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 325
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer 298
Perdita di espressione delle proteine MLH1, MSH2, MSH6 ed instabilità dei microsatelliti nel carcinoma dell'endometrio 296
Evaluation of the Role of BRAFV600E Somatic Mutation on Papillary Thyroid Cancer Disease Persistence: A Prospective Study 289
PML at Mitochondria-Associated Membranes Is Critical for the Repression of Autophagy and Cancer Development 286
Gastrointestinal stromal tumors and other malignancies: A case series 286
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses 283
A New Case of Syringocystadenocarcinoma Papilliferum: A Rare Pathology for a Wide-Ranging Comprehension 279
Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2 277
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 273
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. 268
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 263
Adjuvant chemotherapy in colorectal cancer patients with microsatellite instability - Response 257
Histologic and sonographic features of holmium laser in the treatment of chronic venous disease 256
Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25 253
Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer 250
Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients 248
An apparently untreatable ulcer of the face 247
The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis 247
Amelanotic metastasing melanoma mimicking lung cancer 246
MicroRNA involvement in hepatocellular carcinoma 245
MIR-501 DEPLETION INDUCES CELL CYCLE INHIBITION BY MTOR AND P53 MODULATION IN RENAL CARCINOMA 245
Assessment of MLH1 promoter methylation and BRAF gene mutation in colorectal carcinomas with microsatellite instability 242
Role of MGMT methylation status at time of diagnosis and recurrence for patients with glioblastoma: clinical implications 235
Feasibility of sentinel lymph node (sln) biopsy in colic cancer 235
Loss of cortical GABA terminals in Unverricht–Lundborg disease 232
Fhit protein expression in human gastric cancer and related precancerous lesions 231
Mitochondrial Ca2+ Signaling in Health, Disease and Therapy 229
Colorectal tumors: The histology report 228
Analysis of MLH1 promoter methylation in colorectal carcinomas with microsatellite instability 228
Detection of DNA mutations in urine of patients with prostate cancer by NGS technology 226
N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration 225
MiR501-5p stimulating the activity of mToR may result a risk factor for a poor prognosis of clear cell kidney carcinoma 224
The role of immunohistochemistry in the identification of BRAF V600E mutated colorectal cancer 219
Clinical and technical validation of a genomic classifier (ColoPrint) for predicting outcome of patients with stage II colon cancer. 213
Analysis of BRAF Gene Mutation and MLH1 Promoter Methylation in MSI-H Colorectal Carcinomas with Loss of MLH1 Protein Expression 211
MGMT expression in colorectal cancer: relation to clinicopathologic and molecular features 210
Multigene methylation analysis of gastrointestinal tumors: TPEF emerges as a frequent tumor-specific aberrantly methylated marker that can be detected in peripheral blood 209
Class 1, 2, and 3 BRAF-Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular Characterization 209
Medullary-type poorly differentiated adenocarcinoma of the large bowel: A distinct clinicopathologic entity characterized by microsatellite instability and improved survival 207
Biologic characterization of hereditary non-polyposis colorectal cancer: Nuclear ploidy, AgNOR count, microvessel distribution, oncogene expression, and grade-related parameters 204
Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer 203
Pathologic and molecular features of BRAF mutated colorectal adenocarcinomas 203
SARS-CoV-2 nucleocapsid-protein and ultrastructural modifications in small bowel of a four week negative COVID-19 patient 203
microRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer 202
Genomic classifier coloprint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors 201
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer 200
Feasibility of sentinel lymph node (sln) byopsy in colic cancer 200
High-grade synovitis associates with clinical markers and response to therapy in chronic inflammatory arthritis: post hoc analysis of a synovial biomarkers prospective cohort study 199
Differential expression of A3 adenosine receptors in colorectal cancer and related mucosa: a mirror in blood cells. 199
Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability. 199
Frequent aberrant methylation of the CDH4 gene-promoter in human colorectal and gastric cancer 199
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 199
MicroRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer 198
Hsa-microRNA-1249-3p/Homeobox A13 axis modulates the expression of β-catenin gene in human epithelial cells 197
Ependymomas, Malignant Tumors of Pancreatic Islets, and Osteosarcomas Induced in Hamsters by BK Virus, a Human Papovavirus 196
SLUG/HIF1-α/miR-221 regulatory circuit in endometrial cancer 195
Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells 194
Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study 193
Segmented filamentous bacteria-like organisms in histological slides of ileo-cecal valves in patients with ulcerative colitis 192
The prognostic role of gender and MGMT methylation status in glioblastoma patients: The female power 192
Modulation of mismatch repair and genomic stability by miR-155 190
The first two years of colorectal cancer screening in Ferrara, Italy 188
PML at mitochondria-associated membranes governs a trimeric complex with NLRP3 and P2X7R that modulates the tumor immune microenvironment 181
Oncogenic role of miR-483-3p at the IGF2/483 locus 180
Relapses of primary cutaneous anaplastic large-cell lymphoma in a female immunocompetent patient with persistent chlamydophila pneumoniae and human herpesvirus 8 infection 180
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 178
Immunohistochemical evaluation of mismatch repair proteins in colorectal carcinoma: the AIFEG/GIPAD proposal 177
A microRNA expression signature of human solid tumors defines cancer gene targets 176
Colorectal cancer screening in Ferrara: Results in early (2005-2009) and late (2009-2013) screening periods and surgical treatment of the screenees versus pre-screening (2003-2005) unselected population. 176
Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis 175
Detection of disease-causing mutations in prostate cancer by NGS sequencing 175
Inflammatory Microenvironment in Early Non-Small Cell Lung Cancer: Exploring the Predictive Value of Radiomics 174
p53 Expression in colorectal cancer: Relation to tumor type, DNA ploidy pattern, and short-term survival 173
Anti-miR-135b in colon cancer treatment 170
Epigenetic Regulation: A Link between Inflammation and Carcinogenesis 169
Microsatellite instability in multiple colorectal tumors 168
p53 protein expression in the colorectal adenoma-carcinoma sequence 168
Espressione del gene MGMT nel carcinoma colo-rettale: correlazioni cliniche, patologiche e biomolecolari 168
MicroRNA501 may affect the aggressiveness of clear cell renal carcinoma 166
Third Round of Colorectal Cancer Screening in Ferrara (2009-2011): Prevalence of Colorectal Cancer and Advanced Adenoma and Comparison with a 2-year Prescreening Period (2003-2005) 165
Tofacitinib restores psoriatic arthritis fibroblast-like synoviocytes function via autophagy and mitochondrial quality control modulation 163
Identification and classification of Hereditary Nonpolyposis Colorectal Cancer (Lynch syndrome): adapting old concepts to recent advancements. Report from the Italian Association for the Study of Hereditary Colorectal Tumors Consensus Group 163
Effect of vaccination with autologous tumor-loaded dendritic cells on intratumoral regulatory T cells in metastatic melanoma patients 162
Evaluation of the Synovial Effects of Biological and Targeted Synthetic DMARDs in Patients with Psoriatic Arthritis: A Systematic Literature Review and Meta-Analysis 161
Sensitive and specific detection of lung cancer DNA in bronchial washing by a novel methylation-specific droplet digital PCR 159
Late-onset intrauterine growth restriction and HHV-6 infection: A pilot study 159
Valutazione di parametri prognostici nel carcinoma del colon-retto. II. Ploidia mediante citometria a flusso. 158
Methylenetetrahydrofolate reductase 677 C -> T polymorphism and risk of proximal colon cancer in North Italy 156
Instabilità dei microsatelliti ed espressione delle proteine del mismatch repair nel carcinoma endometriale 155
Screening patologico per la identificazione dei tumori colo-rettali con deficit del DNA mismatch repair 152
Cost-effectiveness of colonoscopy colorectal cancer (CRC) screening in asymptomatic increased risk subjects 151
Prognostic value of microsatellite instability and intratumor activated cytotoxic lymphocytes in colon cancer 151
Preoperative endoscopic tattooing to mark the tumour site does not improve lymph node retrieval in colorectal cancer: A retrospective cohort study 150
Targeted Sequencing Approach For Prostate Cancer Using Ion Torrent Personal Genome Machine (PGM ™) Platform 150
Nothing but lung and bones: Longitudinal evolution and quantitative analysis in a case of idiopathic diffuse pulmonary ossification 147
Totale 22.498
Categoria #
all - tutte 130.764
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.764


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.302 0 0 109 64 79 75 67 107 57 139 123 482
2022/20231.663 171 111 73 199 217 200 90 157 207 40 113 85
2023/20241.273 101 135 77 44 107 203 84 104 44 55 66 253
2024/20254.416 128 122 327 229 441 427 256 238 718 421 671 438
2025/202611.851 1.089 469 866 1.324 1.597 834 1.449 649 1.144 1.256 708 466
2026/20271.520 410 666 444 0 0 0 0 0 0 0 0 0
Totale 30.807